Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity

NCT06978777 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-01-23

No results posted yet for this study

Summary

The purpose of the study is to asses brown adipose tissue activity after a cold mild stimulus, preceded by 200mg caffeine or placebo administration.

Conditions

  • Brown Adipose Tissue (BAT) Physiology
  • Cold Exposure

Interventions

DRUG

Caffeine (200 mg)

single dose of 200mg caffeine orally in study visit A

DRUG

Placebo

single dose of 1 tablet Placebo in study visit B

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Matthias Betz, Prof. · University Hospital, Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-21
Primary Completion
2026-05-31
Completion
2026-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06978777 on ClinicalTrials.gov